FDA Drug/Biologics Approval BLA 125031 S-175, PEGFILGRASTIM

FDA Drug/Biologics Approval BLA 125031 S-175, PEGFILGRASTIM

Regular price $149.00 USD
Regular price Sale price $149.00 USD
Sale Sold out
BLA 125031 S-175
Company: AMGEN
Drug Name: NEULASTA
Active Ingredients: PEGFILGRASTIM
Strength: 6MG/0.6ML
Dosage Form/Route: SYRINGE
Action Date: 01/31/2002
Marketing Status: Prescription
Submission Classification: ORIG-1

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details